Rebecca Petersen's most recent trade in CapsoVision Inc. was a trade of 24,834 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on Aug. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CapsoVision Inc. | Rebecca Petersen | Director of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.37 per share. | 18 Aug 2025 | 24,834 | 24,834 | - | 0.4 | 9,097 | Common Stock |
| CapsoVision Inc. | Rebecca Petersen | Director of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2025 | 17,327 | 3,694 | - | - | Stock Option (right to buy) | |
| CapsoVision Inc. | Rebecca Petersen | Director of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2025 | 7,507 | 0 | - | - | Stock Option (right to buy) |